Pharmicell

005690 · KOSPI · Information Technology · SMALL CAP

A new supply contract.

Pharmicell disclosed a supply contract with Doosan Corporation Electronics BG, worth US$6.39M, about 14.18% of its recent annual revenue, running through Apr 2026.

Supply contract(Supply contract signed)· FILED 2026-02-19· RCEPT 20260219800088

US$6.39MContract value
14.18%vs. recent revenue
Apr 2026Throughfrom Feb 2026

Converted at 1 USD ≈ ₩1,440.16 (filing-date rate, 2026-02-19 close)

What happened

Pharmicell disclosed a supply contract with Doosan Corporation Electronics BG, worth US$6.39M, about 14.18% of its recent annual revenue, running through Apr 2026.

For context, this single contract equals about 14.18% of the company's most recent annual revenue.

CounterpartyDoosan Corporation Electronics BG
Contract valueUS$6.39M
vs. recent revenue14.18%
ThroughApr 2026 (from Feb 2026)
Filed2026-02-19, Supply contract signed
SourceDART rcept 20260219800088 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-02-19 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.